UK Coronavirus: Oxford University Is Positive In An Early Vaccine Win

It infects human cells turning them into factories that activate an immune response. It should protect the person against future infections.

UK Coronavirus: Oxford University Is Positive In An Early Vaccine Win - Ravzgadget
Coronavirus vaccine / Photo credit: Daily Sabah

Oxford scientists are confident on their COVID-19 victory vaccine based on their past experience which had been a success on outbreaks vaccination. The University thinks the vaccine could be ready in September.

The government’s chief medical officer still insists that people should practice social distancing to lessen the amount of virus being transmitted to people while the whole world waits for a vaccine that will take 12-18 months until it’s in global use.

Nevertheless, the team at the Jenner Institute of which it’s part of the University of Oxford are adamant that they will have millions of dosages and proof that it’s safe and effective by September.

MORE FROM RAVZGADGET: Playing This Free Game Could Help Find A Coronavirus Vaccine

The team says their past success in technology and contagious diseases is why it will batter the government’s timeline. They have successfully developed similar vaccine technology and other diseases such as MERS and Ebola.

ChAdOx, pronounced as chaddox one is a version of a common cold virus that has been altered not only so that it doesn’t show symptoms but also carries some genetic substance of the Coronavirus.

It infects human cells turning them into factories that activate an immune response. It should protect the person against future infections.

By means of utilizing tried and tested technology, it allows scientists to quicken up the clinical experiment trials. The medical regulators are satisfied that ChAdOx1 is vigorous and safe to be tested on people; the researchers can start trials on healthy volunteers soon.

The scientists are planning to test the effectiveness of the vaccine on healthcare workers who are at risk of contracting the virus. They may go abroad to countries that have a high number of new infections to get the results.

However Britain still has a challenge on manufacturing the vaccine in order to supply it all the affected countries.

Share this article with friends
VIANomsa
SOURCERavzgadget
Chris Hooks is a passionate Senior tech analyst and writer with more than 12 years experience with tech manufacturing companies.
0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments